BIRMINGHAM, Ala., Feb. 5, 2024 /PRNewswire/ -- Encompass Health Corp. (NYSE: EHC), the nation's largest owner and operator of inpatient rehabilitation hospitals, today announced it has been named to Fortune's 'World's Most Admired Companies' list for 2024. "We are honored to be named one of Fortune's World's Most Admired Companies again this year. Receiving this recognition four consecutive years is a testament to the exceptional care we provide and the trust we continue to build with our patients, partners ...

Encompass Health Corporation (EHC) is slated to report fourth-quarter 2023 results on Feb 7, after market close.What Do the Estimates Say?The Zacks Consensus Estimate for Encompass Health’s fourth-quarter earnings per share is pegged at 83 cents compared with 88 cents in the year-ago quarter.The consensus mark for revenues is pegged at $1.2 billion, suggesting 8.8% growth from the year-ago quarter’s reported number.Encompass Health’s bottom line beat estimates in each of the trailing four quarters, the aver ...

Have you been paying attention to shares of Encompass Health (EHC) ? Shares have been on the move with the stock up 7.4% over the past month. The stock hit a new 52-week high of $72.09 in the previous session. Encompass Health has gained 7.4% since the start of the year compared to the -0.9% move for the Zacks Medical sector and the 8.6% return for the Zacks Medical - Outpatient and Home Healthcare industry.What's Driving the Outperformance?The stock has a great record of positive earnings surprises, as it ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 ______________________________ FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Delaware 63-0860407 9001 Liberty Parkway Birmingham, Alabama 35242 (Address of Principal Executive Offices) Commission File Number 001-10315 __________________________ ...

Encompass Health Corporation (NYSE:EHC) Q3 2023 Results Conference Call October 27, 2023 10:00 AM ET Company Participants Mark Miller - Chief Investor Relations Officer Mark Tarr - President, CEO Doug Coltharp - CFO Conference Call Participants A.J. Rice - UBS Ann Hynes - Mizuho Securities Brian Tanquilut - Jefferies Kevin Fischbeck - Bank of America Matt Larew - William Blair Kieran Ryan - Deutsche Bank Operator Good morning, everyone and welcome to Encompass Health's Third Quarter 2023 Earnings Conference ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 ______________________________ FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number 001-10315 ______________________________ Encompass Health Corporation (Exact name of Registrant as specified in its Charter) (State or Other Jurisdic ...

Encompass Health Corporation (NYSE:EHC) Q2 2023 Earnings Call Transcript August 2, 2023 10:00 AM ET Company Participants Mark Miller - Senior Vice President of Investor Relations and Strategic Planning Mark Tarr - CEO, President and Director Doug Coltharp - Executive VP and CFO Conference Call Participants Kevin Fischbeck - Bank of America Andrew Mok - UBS A.J. Rice - Credit Suisse Brian Tanquilut - Jefferies Pito Chickering - Deutsche Bank Steven Valiquette - Barclays Matt Larew - William Blair Scott Fidel ...

☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 ______________________________ FORM 10-Q For the quarterly period ended March 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number 001-10315 ______________________________ Encompass Health Corporation (Exact name of Registrant as specified in its Charter) (State or Other Jurisdi ...

Encompass Health Corporation (NYSE:EHC) Q1 2023 Earnings Conference Call April 28, 2023 10:00 AM ET Company Participants Mark Miller - IR Mark Tarr - President & CEO Doug Coltharp - CFO Conference Call Participants Kevin Fischbeck - Bank of America A.J. Rice - Credit Suisse Pito Chickering - Deutsche Bank Andrew Mok - UBS Ben Hendrix - RBC Capital Markets Brian Tanquilut - Jefferies Ann Hynes - Mizuho Securities Operator Good morning, everyone, and welcome to Encompass Health's First Quarter 2023 Earnings C ...

Hospital Operations and Growth - In 2022, the company operated 153 hospitals, an increase from 145 in 2021 and 137 in 2020, with discharges rising to 211,116 from 197,639 in 2021[26] - The company has increased its number of licensed beds by approximately 56% since 2012, adding around 3,700 beds, and plans to open 8 new hospitals and add 80 to 100 beds to existing hospitals in 2023[35][36] - Approximately 6% of stroke recovery patients in the U.S. were treated at the company's hospitals in 2022, accounting for about 19% of the overall patient mix[39] Financial Performance - Net operating revenues for inpatient services reached $4,251.6 million in 2022, up from $3,918.0 million in 2021, while total revenues increased to $4,348.6 million from $4,014.9 million[26] - Revenues from Medicare and Medicare Advantage represent approximately 80% of total revenues, highlighting the significance of government payments to operations[59] - In 2022, Medicare accounted for 65.3% of the company's total revenue, a slight increase from 64.4% in 2021[60] Medicare and Reimbursement - Medicare Advantage payors represented 15.1% of net operating revenues in 2022, up from 8.4% in 2017, with reimbursement based on case mix group increasing from 58% to 88% during the same period[37] - The company must comply with Medicare rules, including the "60% Rule," which requires at least 60% of patients to have specific qualifying diagnoses[69] - Future changes to Medicare reimbursement rates could materially affect the company's financial position and operations[65] Compliance and Regulatory Environment - The company is subject to significant federal, state, and local regulations that affect reimbursement for services provided[81] - The federal False Claims Act imposes penalties for knowingly presenting false claims, with potential damages equal to three times the overpayment plus up to $25,000 per claim[94] - Compliance with extensive healthcare regulations requires substantial time and expense, and failure to comply could result in significant penalties or operational changes[180] Employee Management and Development - The total employee count as of December 31, 2022, was approximately 35,000, with 20,839 full-time employees, 2,559 part-time employees, and 11,121 pool/per-diem employees[44] - The company reimbursed over $1.2 million in tuition and paid over $2.8 million toward employees' student loan debt in 2022, supporting employee education[52] - The company has invested in technology for on-demand learning and development programs, enhancing employee development opportunities[53] Patient Care and Services - The company aims to enhance patient care through post-acute solutions, leveraging electronic medical record technologies and strategic partnerships[40] - As of December 31, 2022, the company had installed onsite hemodialysis systems in 41 hospitals, improving patient satisfaction and reducing treatment costs[42] - The average age of Medicare patients is approximately 76, with the population aged 75 to 79 expected to grow at about 5% per year through 2026, indicating a rising demand for rehabilitation services[34] Financial Risks and Challenges - The company is experiencing a shift in payor mix from traditional Medicare to Medicare Advantage, which generally results in lower reimbursement rates and potentially higher bad debt[153] - The company has faced challenges related to compliance with Medicare enrollment requirements, with potential terminations from the Medicare program posing a material risk to its financial position[201] - The company is subject to various audits that may challenge the medical necessity of treatments, affecting Medicare claims[139] Cybersecurity and Data Privacy - The company has implemented extensive security measures to protect patient data, but remains vulnerable to cyber threats, which could lead to significant financial and reputational damage[216] - The potential for security breaches involving electronic health data is heightened, which could lead to significant liabilities and reputational harm[196] - Noncompliance with electronic health data regulations could result in civil monetary penalties and exclusion from federal health care programs, adversely affecting the company's operations[195] Market and Competitive Landscape - The company is the largest operator of inpatient rehabilitation hospitals in the U.S., but faces intense competition from acute-care hospitals and other healthcare providers[221] - Approximately 91% of the company's hospital referrals come from acute-care hospitals, making it susceptible to competition from those expanding into post-acute rehabilitation services[221] - Changes in state laws regarding certificate of need (CON) could increase competition, affecting the company's ability to expand operations in certain states[224]